Oxford Science Enterprises
Company Builder / Venture CapitalOxford, United KingdomSee on the mapoxfordscienceenterprises.com
Oxford Science Enterprises is an independent investment company and venture builder that turns Oxford research into companies across deep tech, life sciences and healthtech. It funds ventures from pre-seed to growth.
- 3
- Portfolio companies on reccy
- 0
- Hiring now
- 0
- Open roles in the portfolio
- Oct 2025
- Latest portfolio round
Hiring now in the portfolio0
Apply on each company's siteNone of their companies on reccy has an open role right now. Browse all neurotech roles
Portfolio on reccy3
From company funding recordsTheir companies, round by round
From company funding records- Kneu HealthSeattle, WA
Wearables
- Jan 2026Accelerator/Incubator
- Oct 2025Seed · $5.6MLed
- Sep 2025Accelerator/Incubator
- Jun 2025Accelerator/Incubator
- Jan 2025Seed VC - II
- Jan 2025Biz Plan Competition - II
- Amber TherapeuticsLondon, UK
Neuromodulation
- Mar 2026Non-equity assistance
- UndatedSeries A
- UndatedSeedLed
- UndatedGrant
- ReEmergeEdina, Minnesota, United States
Neuromodulation
- Sep 2026Series A · $37M
Rounds marked Led list Oxford Science Enterprises as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Oct 2025
Kneu Health · Seed $5.6MLead
With Cedars-Sinai IP Company, G. K. Goh Group, Jameel Investment Management Company, SXSW London, Social Impact Enterprises
- Undated
Amber Therapeutics · SeedLead
With 8VC
Portfolio in the news
From the Cortex · last 12 months- Nov 2026
- Nov 2026
- Sep 2026ReEmerge Raises $37M for Precision Thalamic DBS
ReEmerge · Articles | Neurofounders